QUBIGEN
Company

QUBIGEN

Biotechnology Research Parkville, Victoria, Au 7 employees
Employees
7
Contacts
2
Emails
2

QUBIGEN Overview

Headquarters
Parkville, Victoria, Au
Website
www.qubigen.com
Industry
Biotechnology Research
Employees
7
Founded
2024
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About QUBIGEN

Qubigen is an exciting new venture that combines Federated AI technology, quantum chemistry and AI drug design capabilities. Qubigen’s mission is to create the largest global federated proprietary dataset and computational toolbox for AI driven drug design. This means that multiple entities such as pharmaceutical and biotech companies can work on new molecule discoveries at the same time, thereby shortening drug development pipelines. Federated AI enables a global ‘collaborative-first’ approach by significantly increasing the access to health technology to a broader range of collaborators. Bringing together Data Access partners to tackle the world’s toughest diseases, we stand a better chance of developing novel medicines that no single company could develop on their own.

QUBIGEN Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

QUBIGEN Org Chart

Sample employees and titles
Name Title Contact
Andrew Murphy Chief Technology Officer at Presagen
View
Dr Michelle Perugini Head of Commercialisation at Unisa, CEO Unisa Ventures, Board Chair Qubigen
Email
Amir Zalcenstein Managing Director, Synthesis Bioventures
View
David Brooks Product and Operations Manager at Qubigen
Email

Employees by Management Level

Executive 2 profiles
Director 1 profile
Manager 1 profile

Compare Similar Companies to QUBIGEN